Logo della Fondazione Giannino Bassetti


L'innovazione è la capacità di realizzare l'improbabile

Intestazione stampa


Rubrica di segnalazioni a cura della Redazione

Home > News > NIH program explores the use of genomic sequencing in newborn healthcare

NIH program explores the use of genomic sequencing in newborn healthcare

di Redazione FGB [1], 16 Settembre 2013

The US National Institutes of Health has announced that it will spend $25 million over five years to support a program looking into the medical and ethical repercussions of sequencing the DNA of babies.

The awards will fund studies on the potential for genome and exome sequencing to expand and improve newborn health care. Genomic sequencing examines the complete DNA blueprint of the cells, and exome sequencing is a strategy to selectively sequence exons, the short stretches of DNA within our genomes that code for proteins.

Each of the new awards will consist of three parts: Genomic sequencing and analysis; research related to patient care; and the ethical, legal and social implications of using genomic information in the newborn period. Teams of researchers will work to further the understanding of disorders that appear in newborns and to improve treatments for these diseases using genomic information.

Further information is available through the NIH website [2].


(Photo: Baby's First DNA [3] by estonia76 from Flickr)


Mostra/Nascondi i link citati nell'articolo

Link citati nell'articolo:

  1. 1] /schedabiografica/Redazione FGB
  2. 2] http://nih.gov/news/health/sep2013/nhgri-04.htm
  3. 3] http://www.flickr.com/photos/estonia76/4285037015
CC Creative Commons - some rights reserved.
cc - by estonia76 from Flickr


Articoli di: 

Redazione FGB

Ricerca per:
Ricerca nei video:

- Iscriviti alla mailing list - Informativa Cookies - Privacy Policy -

RSS Feed  Valid XHTML  Diritti d'autore - Creative Commons Gruppo Fondazione Giannino Bassetti in Facebook Gruppo Fondazione Giannino Bassetti in Linkedin Segui la Fondazione Giannino Bassetti in twitter

p.i. 12520270153